On this week’s Trending News EU episode, Jack and Ollie discuss a few recent EU-based newsworthy items including the potential for robotics to transform surgical and patient care (0.35), exciting progress being made in Europe to advance decentralised clinical trials (7.26), and much needed hope for those suffering with postpartum depression following approval in the US of an innovative new medicine (15.48).
Podcast Tags: healthcare, healthcare news, robotics, AI, artificial intelligence, NHS, health equity, EU, clinical trials, neuroscience, depression, postpartum depression, major depressive disorder, biogen
Source Links:
- Outdated legacy tech risks driving frustrated staff out of the NHS
- St Bartholomew’s perform first robotic-assisted lung biopsy
- Is Outdated Technology Holding Back UK Surgeons?
- The robotics revolution has arrived, and it is changing how we do surgery
- €60 million committed to establish AI and robotics in healthcare
- Robotic surgery supporting faster recoveries and better outcomes
- Different, But Not Poles Apart: Running Decentralized Clinical Trials In EU & US
- Principles-Based vs Prescriptive: How US & EU Compare In Their Approach To Decentralized Trials
- How clinical trials benefit from decentralized solutions: A Nordic case study
- The trial of the future: using digital technologies to enable decentralized trials
- Decentralized trials getting some attention on the international regulatory front
- No place like home? Stepping up the decentralization of clinical trials
- A new pill in the U.S. offers hope to mothers with postpartum depression
- Postpartum psychosis: new mothers speak out over need for support
- Clinical Efficacy of a 2-Week Treatment Course of Zuranolone for the Treatment of Major Depressive Disorder and Postpartum Depression: Outcomes From the Clinical Development Program
- Impact of new pill to treat postpartum depression will depend on price
- Biogen, Sage’s postpartum depression approval overshadowed by larger rejection
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Jen Burke, Director
Jack Young, Senior Director
Oliver May, Senior Manager
About Vynamic
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, New York, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
Want to learn more? Get in touch!
Related Podcasts:
Responsible AI for Health Services Organizations
When it comes to deploying AI technologies, there are both technical and ethical considerations – in healthcare,...
Listen nowDestination Employer: What It Takes to be a Workplace of Choice for Healthcare Clinicians
AI has taken the business world by storm. It’s having a transformative impact on our industry thrilling and challenging in equal measure—shifting how.
Read more
Michael Hudson
From Theory to Practice: Vynamic’s Hands-On AI Journey
Discover how Vynamic harnesses Generative AI to empower teams, streamline operations, and transform the health industry with hands-on insights.
Read more